Company Overview

Koninklijke Philips N.V., founded in 1891 and headquartered in Amsterdam, the Netherlands, has transformed from its lighting origins into a focused healthcare technology leader. As of September 9, 2025, the company holds a market capitalization of $26.74 billion and employs 67,263 individuals worldwide. Philips serves a global customer base across North America, Greater China, and other international markets, driving innovation across the healthcare continuum.

Business Segments

Philips operates through three primary business segments, each addressing critical areas of healthcare:

Diagnosis & Treatment

This segment comprises systems, smart devices, software, and services powered by AI-enabled informatics. These solutions support precision diagnoses and minimally invasive procedures across therapeutic areas such as cardiology, peripheral vascular, neurology, surgery, and oncology. It includes diagnostic imaging solutions like magnetic resonance imaging (MRI), X-ray systems, computed tomography (CT) systems with detector-based spectral CT, ultrasound imaging for diagnosis and treatment planning, integrated interventional X-ray systems, and interventional image devices for procedures in coronary, peripheral vascular, and heart rhythm management.

Connected Care

The Connected Care segment encompasses Hospital Patient Monitoring, Emergency Care, Sleep & Respiratory Care, and Connected Care Informatics. The company offers acute patient management solutions, emergency care systems, patient care management for ambulatory and home settings, specialized sleep and respiratory care products, and vendor-agnostic software solutions designed to improve patient outcomes and care efficiency.

Personal Health

Focused on supporting healthier lifestyles and managing chronic diseases, the Personal Health segment delivers integrated, connected solutions. It covers the entire health continuum and includes offerings in Oral Healthcare, Personal Care, and Mother and Child Care, aiming to empower consumers and patients in their health journeys.

Financial Performance

2024 Full Year Results

For the full year 2024, Philips reported sales of EUR 18.0 billion, with comparable sales growth of 1%. In Q4 2024, sales reached EUR 5.0 billion, also showing 1% comparable sales growth, despite a double-digit decline in the China market.

Key financial highlights for 2024 include:

• Income from Operations: EUR 529 million (Full Year), EUR 199 million (Q4)

• Adjusted EBITA: Increased by 90 basis points to 11.5% for the full year.

• Free Cash Flow: EUR 0.9 billion for the full year 2024.

• Proposed Dividend: Maintained at EUR 0.85 per share, with options for shares or cash.

Quarterly Performance (Q4 2024)

For the fourth quarter of 2024:

• Adjusted EBITA: Increased by 60 basis points to 13.5%, driven by operational improvements and productivity measures.

• Free Cash Flow: Increased to EUR 1.3 billion in the quarter, benefiting from Respironics insurance proceeds, partly offset by working capital phasing.

Strategic Initiatives and Transformation

Philips is actively executing a comprehensive three-year transformation plan focused on achieving operational excellence and optimizing market positioning. The company is simplifying its operating model, granting end-to-end Businesses single accountability, supported by leaner central Functions and robust customer-facing organizations in its Regions and countries.

Leadership and Talent

Since the inception of the transformation plan, 75% of executive hires have come from a health technology background. Philips has made strategic appointments to bolster its leadership team across key regions and business functions, ensuring strong governance and strategic direction.

Productivity Improvements

Productivity initiatives are performing ahead of schedule, delivering EUR 163 million in savings during Q4. This includes EUR 47 million from operating model savings, EUR 56 million from procurement, and EUR 59 million from other programs. The company has raised its productivity savings target for the 2023-2025 period from EUR 2 billion to EUR 2.5 billion, with EUR 800 million targeted for 2025.

Market Challenges and Resilience

While Philips demonstrated solid global performance, the company encountered headwinds in the Chinese market. Group comparable sales increased by 1% globally, with robust growth of 5% in the rest of the world, which was largely counterbalanced by a double-digit decline in China, where market conditions are anticipated to remain uncertain. Despite these regional challenges, comparable order intake and sales increased by 1% for the full year, and by 4% when excluding China.

Corporate Values and Mission

Philips is committed to strengthening its culture of impactful care, acting with integrity, and prioritizing patient safety and quality above all else. The company remains dedicated to delivering sustainable healthcare solutions while maintaining its core focus on innovation and operational excellence.

Philips continues to solidify its position as a leader in healthcare technology, leveraging its diversified portfolio across the healthcare continuum to serve hospitals, healthcare professionals, and consumers worldwide. The company's strategic focus on AI-enabled solutions, continuous operational improvements, and targeted market positioning supports its long-term growth objectives within the dynamic healthcare landscape.